ConductScience.org, home

Gene · 406932

MIR140: microRNA 140

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR140: microRNA 140. Genes, record 406932. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/406932

On this page

Gene

Symbol
MIR140
HGNC
Name
microRNA 140
HGNC
NCBI Gene ID
406932
NCBI Gene
HGNC ID
HGNC:31527
HGNC
Ensembl
ENSG00000208017
NCBI Gene
Aliases
MIR-140, MIRN140, SEDN, hsa-mir-140, miRNA140, mir-140
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,012

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR140 papersNewest fiscal year
T32CA154274Training Grant in Cancer Biology92025
P30CA016058Cancer Center Support Grant62025
P30CA016672Cancer Center Support Grant52025
P30CA134274UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT42025
P01HL116263HDL Function in Human Disease32025
P30AG028740University of Florida Older Americans Independence Center (OAIC)32025
P30CA036727Buffett Cancer Center Support Grant32025
P30ES005022Rutgers Center for Environmental Exposure and Disease (CEED)32025
P30ES006694Southwest Environmental Health Sciences Center32025
R01AA012404Gene Expression in the Human Alcoholic Brain32025

1 to 10 of 1,012Source NIH's project files

See all 1,012 nih grants

Papers3,316

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Effectiveness and multidimensional mechanisms of close-to-bone needling in knee osteoarthritis: a randomized controlled trial.Am J Transl Res202642769246PubTator, text miningPubMed
Non-coding RNAs and Mitochondrial Dysfunction in Alzheimer's Disease: A Systematic Review.Mol Neurobiol202642736501PubTator, text miningPubMed
MicroRNAs as Key Regulators of Degeneration and Inflammation in Osteoarthritis: A Narrative Review.Saudi J Med Med Sci202642621662PubTator, text miningPubMed
The Investigation of MicroRNA Expression Levels in Postmortem Nucleus Accumbens of the Individuals with 6-MAM-Confirmed Heroin-Associated Polysubstance İntoxication: A Case Control Study.Mol Neurobiol202642518030PubTator, text miningPubMed
Effects of medical mud-pack therapy on inflammatory gene expression and clinical outcomes in patients with knee osteoarthritis.Int J Biometeorol202642474806PubTator, text miningPubMed
Large-Scale Production of Secretome From Human Dental Pulp Stem Cells for Articular Cartilage Regeneration.Stem Cells Int202642472184PubTator, text miningPubMed
The mechanisms of myricetin and quercetin in regulating miRNA-140 and MMP/TIMP signaling pathway in osteoarthritis treatment.Pak J Pharm Sci202642262200PubTator, text miningPubMed
A sulfate-arsenical-ferruginous water affects apoptosis, oxidative stress and the gene expression of inflammatory mediators and of a panel of MicroRNA in IL-1β stimulated human osteoarthritic chondrocytes.
Front Med (Lausanne)202642089049PubTator, text miningPubMed
Altered microRNA expression profiles in the postmortem prefrontal cortex of individuals with alcohol use disorder: a case-control study.Eur Arch Psychiatry Clin Neurosci202642053595PubTator, text miningPubMed
Mapping the Natural History of Benign DICER1-Related Lesions and Identifying Predictors of Malignancy.Fortune J Health Sci202642051918PubTator, text miningPubMed

1 to 10 of 3,316

See all 3,316 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/406932

GET https://conductscience.org/api/genes/v1/406932/grants?page=2